依达拉奉联合神经节苷脂对脑梗死患者神经功能缺损症状和生活能力的影响

目的：探讨依达拉奉联合神经节苷脂对急性脑梗死患者神经功能缺损症状和生活能力的影响。方法选取该院收治的急性脑梗死患者112例，随机分为观察组和对照组各56例。对照组患者接受急性脑梗死诊疗常规治疗，观察组患者在对照组治疗方案的基础上加用依达拉奉和神经节苷脂静脉滴注，疗程为2周。采用美国国立卫生院神经功能缺损评分（NIHSS）和Barthel指数对比两组患者的神经功能缺损症状和生活能力改善情况。结果治疗2周后，观察组患者的NIHSS评分为（7．59±4．46）分，ADL评分为（63．44±9．35）分；对照组患者的NIHSS评分为（14．34±6．17）分，ADL评分为（54．46±9．06）分。两组患者治疗2周后的NIHSS评分均显著低于治疗前，而ADL评分均显著高于治疗前（P＜0．05）；治疗1、2周后观察组的NIHSS评分均显著低于对照组，而ADL评分均显著高于对照组（P＜0．05）。出院2个月后，观察组的基本痊愈率为44．64％，总有效率为85．71％；对照组的基本痊愈率为23．21％，总有效率为64．29％。观察组的基本痊愈率和总有效率均显著高于对照组（ P＜0．05）。结论依达拉奉联合神经节苷脂可进一步提高急性脑梗死的临床疗效，更好地改善急性脑梗死患者的神经功能缺损症状和生活能力。

Neurologic function and life ability improvement after Edaravone combined with Ganglioside treatment in cerebral infarction patients

Objective To investigate the neurologic function and life ability improvement after Edaravone combined with Ganglioside treatment in cerebral infarction patients .Methods 112 patients with acute cerebral infarction were selected in our hos-pital and randomly divided into observation group and control group with 56 cases in each group .Subjects in the control group were given routine treatment of acute cerebral infarction .And subjects in the observation group ,based on the treatment of control group , were treated with Edaravone and Ganglioside .The course of treatment was 2 weeks .NIHSS score and ADL score were used to com-pare the neurologic function and life ability improvement of the patients in two groups .Results After 2 weeks of treatment ,the score of NIHSS and ADL of the observation group were (7 .59 ± 4 .46) and (63 .44 ± 9 .35) ,and the control group were (14 .34 ± 6 .17) and (54 .46 ± 9 .06) .The NIHSS scores of the two groups were significantly lower than that before the treatment ,while the ADL scores were significantly higher than that before the treatment(P<0 .05) .In 1 week and 2 weeks of treatment ,the NIHSS scores of the observation group were significantly lower than the control group ,while the ADL scores were significantly higher than the control group (P<0 .05) .2 months after discharge ,the basic recovery rate and total effective rate of the observation group were 44 .64% and 85 .71% ,and the control group were 23 .21% and 64 .29% .The basic recovery rate and total effective rate of the ob-servation group were significantly higher than the control group(P<0 .05) .Conclusion Edaravone combined with Ganglioside can improve the efficiency in patients with acute cerebral infarction ,and improve the neurologic functions and life abilities .